Kriti Nutrients Ltd. Q3 FY26 Unaudited Financial Results Approved
Kriti Nutrients Limited's Board approved unaudited standalone and consolidated results for Q3 FY26. Revenue from operations for the quarter was ₹22430.73 lakh, and net profit after tax was ₹921.27 lakh. Consolidated net profit after tax for the quarter was ₹915.58 lakh. Auditors issued an unmodified review report.
The announcement of financial results is a material event for investors and stakeholders, impacting investment decisions and company valuation.
The company has announced its financial results, which have been approved by the board and received an unmodified review report from auditors. This indicates a routine and positive operational update.
Kriti Nutrients Limited announced the outcome of its Board of Directors meeting held on February 5, 2026. The board approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Additionally, the board took on record the Limited Review Report from the statutory auditors for these financial results. The meeting also addressed other routine business agenda items.
The financial results show revenue from operations for the quarter ended December 31, 2025, at ₹22430.73 lakh, and for the nine months ended December 31, 2025, at ₹66628.25 lakh. For the same periods, net profit after tax stood at ₹921.27 lakh and ₹2765.01 lakh, respectively. The consolidated net profit after tax for the quarter was ₹915.58 lakh and for the nine months was ₹2754.07 lakh.
The statutory auditors, M. Mehta & Co., have provided an unmodified review report on both the standalone and consolidated financial results, confirming that they present a true and fair view in accordance with Indian Accounting Standards and SEBI regulations.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.